Author:
Thaçi Diamant,Puig Lluís,Reich Kristian,Tsai Tsen-Fang,Tyring Stephen,Kingo Külli,Ziv Michael,Pinter Andreas,Vender Ronald,Lacombe Aude,Xia Summer,Bhosekar Vaishali,Gilloteau Isabelle,Guana Adriana,Blauvelt Andrew
Reference5 articles.
1. Secukinumab in the treatment of palmoplantar, nail, scalp, and pustular psoriasis;Armstrong;J Clin Aesthet Dermatol,2016
2. Secukinumab inhibition of interleukin-17A in patients with psoriatic arthritis;Mease;N Engl J Med,2015
3. Secukinumab, an interleukin-17A inhibitor, in ankylosing spondylitis;Baeten;N Engl J Med,2015
4. Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate to severe plaque psoriasis: CLEAR, a randomized controlled trial;Thaci;J Am Acad Dermatol,2015
5. Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate-to-severe plaque psoriasis up to 1 year: results from the CLEAR study;Blauvelt;J Am Acad Dermatol,2017
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献